| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |